These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19131794)

  • 1. Fibrolamellar hepatocellular carcinoma in an infant and literature review.
    Cruz O; Laguna A; Vancells M; Krauel L; Medina M; Mora J
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):968-71. PubMed ID: 19131794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
    Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
    Bhaijee F; Locketz ML; Krige JE
    S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
    Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
    Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
    Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical therapy of hepatic fibrolamellar carcinoma].
    Meriggi F; Forni E
    Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH].
    von Schweinitz D; Bürger D; Weinel P; Mildenberger H
    Klin Padiatr; 1992; 204(4):214-20. PubMed ID: 1381454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiorgan resection in combination with intraoperative, hyperthermic chemotherapy in recurrent fibrolamellar hepatocellular carcinoma. An individual therapeutic concept for a 21-year-old patient].
    Braune C; Fangmann J; Scheumann GF; Klempnauer J
    Zentralbl Chir; 2001 Apr; 126(4):318-21; discussion 322. PubMed ID: 11370396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
    Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
    Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.
    Ferrari D; Di Maria G; Fazio N; Codecà C; Fiore J; Luciani A; Oldani S; Maggioni M; Foa P
    Anticancer Drugs; 2008 Sep; 19(8):837-40. PubMed ID: 18690097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrolamellar liver carcinoma: report of two cases and review of the literature].
    Butte JM; Waugh E; Meneses M; Pruzzo R; Carvallo C; Redondo F; Suárez C; Parada H; Amaral H; de La Fuente H
    Rev Med Chil; 2009 Mar; 137(3):394-400. PubMed ID: 19621182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult type vs. Childhood hepatocellular carcinoma--are they the same or different lesions? Biology, natural history, prognosis, and treatment.
    Czauderna P
    Med Pediatr Oncol; 2002 Nov; 39(5):519-23. PubMed ID: 12228910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic artery infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II in the treatment of malignant liver tumors].
    Morita S; Matsumoto S; Odani R
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):689-95. PubMed ID: 2451473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report.
    Okano A; Hajiro K; Takakuwa H; Kobashi Y
    Am J Gastroenterol; 1998 Jul; 93(7):1144-5. PubMed ID: 9672347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful multimodal treatment for aggressive metastatic and recurrent fibrolamellar hepatocellular carcinoma in a child.
    Okur A; Eser EP; Yilmaz G; Dalgiç A; Akdemir ÜÖ; Oğuz A; Karadeniz C; Akyol G; Demiroğullari B; Boyunağa Ö; Pinarli FG
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e328-32. PubMed ID: 24608073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
    Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection].
    Matsushita A; Hanazaki K; Noike T; Nakagawa K; Misawa R; Nakata T; Nomura K; Kobayashi A; Miwa S; Miyagawa S; Kawasaki S
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1327-32. PubMed ID: 14518415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Kojima Y; Iwasa S; Hagihara A
    Jpn J Clin Oncol; 2008 Oct; 38(10):675-82. PubMed ID: 18716041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.